Certain case reports, mostly from areas with a low percentage of G6PD-deficient patients, mentioned the occurrence of hemolysis after HCQ treatment was initiated and urged caution when COVID-19 patients present with low hemoglobin [6,7]. The gene discussed is G6PD; the disease is COVID-19.